Overall, given that the activity of both PIM kinases and Notch1 plays a crucial role in driving tumor growth and progression, attempts are being made to target or co-target these molecules for targeted cancer therapy [1,68,69], which may result in new and potent cancer treatment strategies. The gene discussed is NOTCH1; the disease is cancer.